Login / Signup

Relationship between raltegravir trough plasma concentration and virologic response and the impact of therapeutic drug monitoring during pregnancy.

Sabrina CarvalhoNancy L SheehanSilvie ValoisFatima KakkarMarc BoucherEma FerreiraIsabelle Boucoiran
Published in: International journal of STD & AIDS (2022)
of 0.04 mg/L or greater is a predictor of virologic response in pregnant women. The impact of TDM in pregnancy, however, could not be demonstrated.
Keyphrases
  • pregnant women
  • antiretroviral therapy
  • hiv infected
  • hiv infected patients